(via TheNewswire)

Vancouver, B.C. - TheNewswire - December 1, 2025 – URZ3 Energy Corp. (TSX.V: URZ) (OTCQB: URZEF) (“ URZ3 ” or the “ Company ”) is pleased to announce Dr. Ivy V. Estabrooke has joined URZ3 as a member of the Advisory Board.

“We are very pleased to welcome Dr. Estabrooke to the URZ3 Advisory Board. Her unique combination of national security experience, advanced technology leadership, and direct uranium-sector board experience will add tremendous depth to our strategic planning. Ivy’s background in deploying innovation at scale—particularly in highly regulated environments—aligns perfectly with our vision as we advance URZ3’s U.S.-focused uranium strategy,” stated Darcy Higgs, Director.

About Ivy V. Estabrooke, BA, MS, PhD

Ivy Estabrooke is an innovation executive with years of strategy, oversight, and leadership experience in technology development and deployment in national security and health care environments. Dr. Estabrooke serves on the board of Rare Earths Americas, an exploration stage rare earth company and previously served on the board of Energy Fuels Inc. (NYSE: UUUU; TSX: EFR), a producer of uranium, vanadium, and rare earth minerals. She has served on numerous nonprofit boards, including the Girl Scouts of Utah, BioUtah, and the Utah District Export Council. Dr. Estabrooke started her career leading a technology development portfolio for the US Department of the Navy where she fielded cutting-edge tools to the US Marine Corps, intelligence community, and Special Forces community. She was the executive director of the Utah Science Technology and Research Initiative, a technology-based economic development agency, senior advisor to the Governor of Utah, and an executive at multiple biotech start-ups. She currently advises government, public, and private entities in optimizing their approaches to innovation and technology development for national security, economic, and social impact in her role as Strategic Account Executive - Defense for RTI International, an independent scientific research institute. She holds the NACD.DC and Department of Defense Senior Acquisition Professional certifications.

Dr. Estabrooke is a member of advisory boards at Arizona State University and The University of Texas at Arlington. She is on the board of the Utah chapter of the National Association of Corporate Directors and the Utah District Export Council.

Dr. Estabrooke has a doctorate in neuroscience from Georgetown University, a master’s degree in national resource management from the National Defense University and a bachelor's degree in biological sciences from Smith College. Her leadership has been recognized with the US Navy Meritorious Service Award, the Fed 100, and a Pathfinder Award.

Corporate

The Company also announces that, pursuant to its stock option plan and subject to regulatory acceptance, it has granted an aggregate total of 100,000 incentive stock options to Dr. Estabrooke, subject to certain vesting provisions. These options will be exercisable at a price of $0.335 per common share and will expire on November 28, 2030.

The stock option grant is subject to the receipt of all necessary regulatory filings and TSX-V approvals.

 About URZ3 Energy Corp.

URZ3 Energy Corp. is a resource development company focused on the acquisition and exploration of uranium properties in North America. The Company is dedicated to advancing its portfolio of projects to meet the growing demand for uranium as a clean energy resource, leveraging its team’s extensive experience in ISR uranium exploration, development, and production.

For more information about URZ3 Energy Corp., please visit www.urz3.com .

Contact:

Mark Kolebaba, President and CEO

Telephone: (604) 307-6450
Email: info@URZ3.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary statement regarding forward–looking information

Certain disclosures in this release constitute “forward-looking information” within the meaning of Canadian securities legislation (such statements being referred to as “forward-looking statements”). Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by words such as the following: expects, plans, anticipates, believes, intends, estimates, projects, assumes, potential and similar expressions. Forward-looking statements involve risks, uncertainties and other factors that could cause actual results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from these forward-looking statements include, but are not limited to, variations in the nature, quality and quantity of any mineral deposits that may be located, the Company’s inability to obtain any necessary permits, consents or authorizations required for its planned activities, and the Company’s inability to raise the necessary capital or to be fully able to implement its business strategies. The reader is referred to the Company’s public disclosure record which is available on SEDAR+ ( sedarplus.ca ).  Although the Company believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all.  Except as required by securities laws and the policies of the TSX Venture Exchange, the Company disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Copyright (c) 2025 TheNewswire - All rights reserved.